News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Post-Structural Overhaul, Lonza Inc. Finds Its New Focus


1/24/2014 6:58:37 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Swiss speciality chemicals maker and life sciences group Lonza said it plans to focus on the pharmaceutical and biotech market as it benefits from drugmakers increasingly outsourcing production. The firm, faced with low-cost competition, a strong Swiss franc and higher raw material prices, has been undergoing a structural overhaul since Richard Ridinger took over as Chief Executive in May 2012. Last year, it shut down plants, cut jobs and exited projects including a generic drugs venture with Israel's Teva to try and improve profitability and productivity.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES